Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol.

preprint OA: closed CC-BY-4.0

Abstract

Introduction: Internationally, the prevalence of diabetes is increasing, and with this comes an increase in diabetes related complications. Diabetic foot disease is the most common lower extremity complication in people with diabetes causing 2% of the global disease burden. It, is associated with major morbidity, mortality, and costs to health services. Despite this burden, the incidence and prevalence of diabetic foot disease is unknown in Ireland. This paper presents a protocol for a systematic review to examine the incidence and prevalence of diabetic foot disease in the Irish population. Methods A systematic review will be performed using the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Pubmed, EMBASE, and Lenus, the Irish Health Research repository, will be searched for publications in any language and without restrictions to date. Title, abstract, and full text screening will be carried out independently by two investigators. Publications reporting on the incidence or prevalence of peripheral neuropathy, peripheral artery disease, ulceration, or amputation in people with diabetes in Ireland, from a defined geographical catchment area of Ireland, will be included. Joanna Briggs Institute (JBI) Critical Appraisal tool will be used to assess included studies methodological quality. Results will be reported in line with the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Conclusion The results of this systematic review can be used to inform appropriate stakeholders on the incidence and prevalence of diabetic foot disease in Irish populations, enabling decision making around appropriate use of resources to help prevent, and improve management of this disease. Systematic review registration CRD42023472904
Full text 141,542 characters · extracted from preprint-html · click to expand
Prevalence and incidence of peripheral... | HRB Open Research dataLayer = dataLayer || []; // Standard GTM initialization - Google Consent Mode handles consent automatically (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl+ '>m_auth=hzk0Vc3qFsQYhCrIoHz68A>m_preview=env-1>m_cookies_win=x';f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-MWFK8L5J'); ;window.NREUM||(NREUM={});NREUM.init={distributed_tracing:{enabled:true},privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]}}; ;NREUM.loader_config={accountID:"438030",trustKey:"438030",agentID:"772317073",licenseKey:"97f8f67f26",applicationID:"772317073"} ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"97f8f67f26",applicationID:"772317073",sa:1} ;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */ (()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i {r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u {let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;fn,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s {r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c 2?n-2:0),o=2;o {r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e {r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i 1?r-1:0),i=1;i {e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d {s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u {i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i t.max&&(t.max=e),e 2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i 2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s 1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o 2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})(); const cookieDomain = window.location.hostname; const tld = buildTLD(); function buildTLD() { const domainParts = cookieDomain.split('.'); while (domainParts.length > 2) { domainParts.shift(); } return domainParts.join('.'); } function deleteCookie(cookieName) { if (!cookieName) { return; } const cookiePath = (cookieName.startsWith('retraction_warning_') || cookieName.startsWith('version_warning_')) ? '/articles/' + cookieName : '/'; // Yes, these three slightly different ways to try and remove cookies are necessary document.cookie = cookieName + '=; path=' + cookiePath + '; domain=' + cookieDomain + '; expires=Thu, 01 Jan 1970 00:00:01 GMT;'; document.cookie = cookieName + '=; path=' + cookiePath + '; domain=.' + tld + '; expires=Thu, 01 Jan 1970 00:00:01 GMT;'; document.cookie = cookieName + '=; path=' + cookiePath + '; expires=Thu, 01 Jan 1970 00:00:01 GMT;'; } function deleteGroupCookies(group) { if (!group) { return; } const domainData = OneTrust.GetDomainData(), cookies = domainData.Groups.filter(cookieGroup => cookieGroup.OptanonGroupId === group)[0].Cookies; cookies.forEach(cookie => deleteCookie(cookie.Name)); } function OptanonWrapper() { const cookieConsentGroups = []; for (group of OneTrust.GetDomainData().Groups) { cookieConsentGroups.push(group.OptanonGroupId); } OneTrust.OnConsentChanged(function(e) { const cookieConsentActiveGroups = OnetrustActiveGroups.split(',').filter(activeGroup => activeGroup); cookieConsentGroups.forEach(group => { if (!cookieConsentActiveGroups.includes(group)) { deleteGroupCookies(group); }; }); }); } window.jQuery || document.write(' ') CKEDITOR_BASEPATH='https://hrbopenresearch.org/js/vendor/ckeditor/' window.reactTheme = 'HRB'; window.MathJax = { CommonHTML: { linebreaks: { automatic: true } }, 'HTML-CSS': { linebreaks: { automatic: true } }, SVG: { linebreaks: { automatic: true } }, AuthorInit: function() { MathJax.Hub.Register.MessageHook('End Process', function () { let timeout = false; // holder for timeout id const delay = 250; // delay after event is "complete" to run callback const reflowMath = function() { const dispFormulas = document.querySelectorAll('.disp-formula.panel'); if (!dispFormulas) { return; } for (const dispFormula of dispFormulas) { const child = dispFormula.querySelector('.MathJax_Preview').nextSibling.firstChild; const isMultiline = MathJax.Hub.getAllJax(dispFormula)[0].root.isMultiline; if (dispFormula.offsetWidth < child.offsetWidth || isMultiline) { MathJax.Hub.Queue(['Rerender', MathJax.Hub, dispFormula]); } } }; window.addEventListener('resize', function() { clearTimeout(timeout); // clear the timeout timeout = setTimeout(reflowMath, delay); // start timing for event "completion" }); }); }, }; if (window.location.hash == '#_=_'){ window.location = window.location.href.split('#')[0] } !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function() {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)} ;if(!f._fbq)f._fbq=n; n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0; t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); fbq('init', '1641728616063202'); fbq('track', "PixelInitialized", {}); Skip to content HRB Open Research file_upload Submit your research search clear search menu close clear Search Browse Gateways & Collections How to Publish Submit your Research My Submissions Article Guidelines Article Guidelines (New Versions) Data Guidelines Prepublication Checks Production Process Article Processing Charges Finding Article Reviewers About How it Works For Reviewers National Steering Group Policies Glossary FAQs Contact Blog My Account Submissions Content and Tracking Alerts My Details Sign In file_upload Submit your research { "@context": "https://schema.org", "@type": "ScholarlyArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://hrbopenresearch.org/articles/7-1" }, "headline": "Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower...", "datePublished": "2024-01-03T12:16:05", "dateModified": "2024-08-21T11:44:10", "author": [ { "@type": "Person", "name": "Sinead Kavanagh" }, { "@type": "Person", "name": "Jennifer A. Pallin" }, { "@type": "Person", "name": "Ann Sinead Doherty" }, { "@type": "Person", "name": "Peter Lazzarini" }, { "@type": "Person", "name": "Linda O'Keeffe" }, { "@type": "Person", "name": "Claire M Buckley" } ], "publisher": { "@type": "Organization", "name": "HRB Open Research", "logo": { "@type": "ImageObject", "url": "https://hrbopenresearch.org/img/AMP/HRB_image.png", "height": 566, "width": 60 } }, "image": { "@type": "ImageObject", "url": "https://hrbopenresearch.org/img/AMP/HRB_image.png", "height": 1200, "width": 127 }, "description": " Introduction Internationally, the prevalence of diabetes is increasing, and with this comes an increase in diabetes related complications. Diabetic foot disease is the most common lower extremity complication in people with diabetes causing 2% of the global disease burden. It, is associated with major morbidity, mortality, and costs to health services. Despite this burden, the incidence and prevalence of diabetic foot disease is unknown in Ireland. This paper presents a protocol for a systematic review to examine the incidence and prevalence of diabetic foot disease in the Irish population. Methods A systematic review will be performed using the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Pubmed, EMBASE, and Lenus, the Irish Health Research repository, will be searched for publications in any language and without restrictions to date. Title, abstract, and full text screening will be carried out independently by two investigators. Publications reporting on the incidence or prevalence of peripheral neuropathy, peripheral artery disease, ulceration, or amputation in people with diabetes in Ireland, from a defined geographical catchment area of Ireland, will be included. Joanna Briggs Institute (JBI) Critical Appraisal tool will be used to assess included studies methodological quality. Results will be reported in line with the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Conclusion The results of this systematic review can be used to inform appropriate stakeholders on the incidence and prevalence of diabetic foot disease in Irish populations, enabling decision making around appropriate use of resources to help prevent, and improve management of this disease. Systematic review registration CRD42023472904 " } { "@context": "http://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": "1", "item": { "@id": "https://hrbopenresearch.org/", "name": "Home" } }, { "@type": "ListItem", "position": "2", "item": { "@id": "https://hrbopenresearch.org/browse/articles", "name": "Browse" } }, { "@type": "ListItem", "position": "3", "item": { "@id": "https://hrbopenresearch.org/articles/7-1/v2", "name": "Prevalence and incidence of peripheral neuropathy, peripheral artery..." } } ] } Home Browse Prevalence and incidence of peripheral neuropathy, peripheral artery... ALL Metrics - Views Downloads Get PDF Get XML Cite How to cite this article Kavanagh S, Pallin JA, Doherty AS et al. Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.12688/hrbopenres.13823.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. Close Copy Citation Details Export Export Citation Sciwheel EndNote Ref. Manager Bibtex ProCite Sente EXPORT Select a format first Track Share ▬ ✚ Study Protocol Revised Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] Sinead Kavanagh 1,2 , Jennifer A. Pallin https://orcid.org/0000-0003-1434-6152 1 , Ann Sinead Doherty https://orcid.org/0000-0003-4149-1574 3 , Peter Lazzarini 4,5 , Linda O'Keeffe 1 , Claire M Buckley https://orcid.org/0000-0002-3174-7022 1 Sinead Kavanagh 1,2 , Jennifer A. Pallin https://orcid.org/0000-0003-1434-6152 1 , [...] Ann Sinead Doherty https://orcid.org/0000-0003-4149-1574 3 , Peter Lazzarini 4,5 , Linda O'Keeffe 1 , Claire M Buckley https://orcid.org/0000-0002-3174-7022 1 PUBLISHED 21 Aug 2024 Author details Author details 1 School of Public Health, University College Cork, Cork, County Cork, Ireland 2 Department of Endocrinology, Bantry Hospital, Bantry, Cork, Ireland 3 Department of General Practice, University College Cork, Cork, County Cork, Ireland 4 School of Public Health and Social Work,, Queensland University of Technology, Brisbane, Queensland, Australia 5 Allied Health Research Collaborative, The Prince Charles Hospital, Brisbane, Queensland, Australia Sinead Kavanagh Roles: Conceptualization, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing Jennifer A. Pallin Roles: Conceptualization, Methodology, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing Ann Sinead Doherty Roles: Methodology, Supervision, Writing – Review & Editing Peter Lazzarini Roles: Methodology Linda O'Keeffe Roles: Methodology, Writing – Review & Editing Claire M Buckley Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing OPEN PEER REVIEW DETAILS REVIEWER STATUS Abstract Introduction Internationally, the prevalence of diabetes is increasing, and with this comes an increase in diabetes related complications. Diabetic foot disease is the most common lower extremity complication in people with diabetes causing 2% of the global disease burden. It, is associated with major morbidity, mortality, and costs to health services. Despite this burden, the incidence and prevalence of diabetic foot disease is unknown in Ireland. This paper presents a protocol for a systematic review to examine the incidence and prevalence of diabetic foot disease in the Irish population. Methods A systematic review will be performed using the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Pubmed, EMBASE, and Lenus, the Irish Health Research repository, will be searched for publications in any language and without restrictions to date. Title, abstract, and full text screening will be carried out independently by two investigators. Publications reporting on the incidence or prevalence of peripheral neuropathy, peripheral artery disease, ulceration, or amputation in people with diabetes in Ireland, from a defined geographical catchment area of Ireland, will be included. Joanna Briggs Institute (JBI) Critical Appraisal tool will be used to assess included studies methodological quality. Results will be reported in line with the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Conclusion The results of this systematic review can be used to inform appropriate stakeholders on the incidence and prevalence of diabetic foot disease in Irish populations, enabling decision making around appropriate use of resources to help prevent, and improve management of this disease. Systematic review registration CRD42023472904 READ ALL READ LESS Keywords Diabetic foot disease, foot ulceration, amputation, Irish health system, incidence, prevalence. Corresponding Author(s) Jennifer A. Pallin ( [email protected] ) Close Corresponding author: Jennifer A. Pallin Competing interests: No competing interests were disclosed. Grant information: Health Research Board Ireland [CDA-2019-007]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Copyright: © 2024 Kavanagh S et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. How to cite: Kavanagh S, Pallin JA, Doherty AS et al. Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.12688/hrbopenres.13823.2 ) First published: 03 Jan 2024, 7 :1 ( https://doi.org/10.12688/hrbopenres.13823.1 ) Latest published: 21 Aug 2024, 7 :1 ( https://doi.org/10.12688/hrbopenres.13823.2 ) Revised Amendments from Version 1 The protocol has been revised following peer review. In the abstract and introduction, we have now emphasized the global relevance this piece of work will have. We have included additional points for data extraction. These include information relating to sociodemographic information, whether participants live urban or rural and there mobility. The protocol has been revised following peer review. In the abstract and introduction, we have now emphasized the global relevance this piece of work will have. We have included additional points for data extraction. These include information relating to sociodemographic information, whether participants live urban or rural and there mobility. See the authors' detailed response to the review by Zena Moore See the authors' detailed response to the review by Adrian H Heald READ REVIEWER RESPONSES Introduction Globally, the prevalence and incidence of type 1 and type 2 diabetes mellitus continues to increase 1 . With an increase in diabetes prevalence, comes an increase in diabetes related macrovascular complications, including cardiovascular, cerebrovascular, and peripheral artery disease, and microvascular complications including retinopathy, peripheral neuropathy, and nephropathy. Peripheral neuropathy and peripheral artery disease are significant risk factors for diabetic foot ulcers and lower limb amputations, each of which place a significant negative burden on those affected and on health systems, resulting in increased risk of death, poorer quality of life and significant costs to health systems 2 – 8 . Diabetic foot disease has also found to cause 2% of the global disease burden 9 . In addition, the risk of a person undergoing a lower-extremity amputation is 22 times higher in a person with diabetes when compared to a person without and up to 80% of diabetes related amputations are preceded by a diabetic foot ulcer 10 , 11 . It is estimated that globally, up to 26.1 million people with diabetes will develop a diabetic foot ulcer 12 . The risk of death in those with diabetic foot ulcers, is almost twice as high when compared to those with diabetes who have never experienced an ulcer 2 . This risk of mortality is also higher in those who have higher levels of socio-economic deprivation 13 . To reduce the morbidity and mortality associated with these complications, timely access to appropriate health services is necessary. In line with international recommendations, this involves identifying and referring those with risk factors for ulceration and amputation to appropriate diabetic foot prevention and management services 14 . However, evidence suggests that many people are not being screened for risk factors and there is insufficient staff to deal with service demands on diabetic foot services 15 , 16 . One way of overcoming this is by ensuring enough resources (e.g., healthcare professionals, infrastructures, and finances) are in place to provide screening for risk factors, and implementation of prevention and management strategies for the foot at-risk of ulceration and amputation. To ensure this, up-to-date population level estimates of the incidence and prevalence of these complications are required to identify public health priorities and allow for appropriate health service planning. Previously published systematic reviews and meta-analyses have estimated a global prevalence of 6.3% for diabetic foot ulcers, with higher prevalence in North America (13%) and Africa (7.2%), and lower prevalence in Europe (5.1%), Asia (5.5%), and Oceania (3%) 17 . Regarding diabetic foot disease, it is estimated that between 19–34% of people with diabetes will develop this throughout their lifetime, with further evidence suggesting that years lived with diabetic foot disease is increasing globally 18 . In Ireland a national diabetes registry does not exist. Thus, prevalence of diabetes and associated complications are based on estimates 19 . Reports suggest that the incidence of diabetes related amputations is increasing 20 , however, little is known about the incidence or prevalence of other diabetes related lower extremity complications. This study describes a protocol for a systematic review aiming to identify and synthesise the incidence and prevalence of diabetes related lower extremity complications in Irish populations. Methods This protocol was developed using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols Checklist (PRISMA-P), and the Joanna Briggs Institute Manual for systematic reviews 21 – 23 . The protocol has been registered prospectively on PROSPERO database for systematic reviews (registration number CRD42023472904). Study aim To identify and synthesise the incidence and prevalence of diabetes related lower extremity complications in Irish populations. Objectives To identify the following incidences and prevalence in Ireland: 1. Diabetes related peripheral neuropathy. 2. Diabetes related peripheral artery disease. 3. Diabetes related foot ulceration. 4. Diabetes related lower extremity amputations (total, major and minor). Eligibility criteria Population: Studies including people residing in the Republic of Ireland with a diagnosis of diabetes, and at least one of the following complications: peripheral neuropathy, peripheral artery disease, foot ulceration, and minor or major lower extremity amputation 24 . Studies will be excluded if data relating to the Irish population cannot be separated from other population groups (e.g., those from the United Kingdom), and where we cannot not differentiate between those with and without a diagnosis of diabetes. The populations of interest for this review will need to be populations from a defined geographical catchment area of Ireland (e.g., national population, inpatient population etc) due to the requirement of a clearly defined denominator. Publication from a single centre(s) will be excluded, unless general or diabetes-population information for the selected centres is provided or if data is adjusted or compared to the overall Irish population demographics. Settings: Studies carried out in community settings (including GP settings, primary care centre etc) and hospital settings (including inpatient and outpatient) will be included. Study design: Prospective and retrospective cross-sectional, case-control or cohort studies will be included. Case reports, case series, and grey literature including reports published by public bodies and informal communications will be excluded. Also, studies that do not report original data will be excluded. There will be no restrictions on year of publication and language. Outcomes The outcomes of interest will be prevalence or incidence of peripheral neuropathy, peripheral artery disease, ulceration, and amputation, as defined by the International Working Group for the Diabetic Foot (IWGDF) 24 . Search strategy The following databases will be searched: ‘PubMed’, ‘EMBASE’, and the Irish Health Research repository ‘Lenus’ will be used. The Condition Context Population (CoCoPop) framework 22 was used to inform development of the search strategy, which was developed in Embase (See Box 1 ) and will be adapted for use in PubMed and the Irish Health Research repository ‘Lenus’. The search strategy will utilise keywords associated with the concepts of diabetic foot disease and incidence and prevalence. Boolean operators AND, OR and proximity operators will be utilised to combine search headings, where appropriate. Backward citation searching of articles selected for full text review will also be carried out. Box 1. Embase Search 1. peripheral AND ('neuropathy'/exp OR neuropathy) 2. 'ischemia'/exp OR 'ischemia' 3. 'peripheral vascular disease'/exp OR 'peripheral vascular disease' 4. #2 OR #3 5. 'ulcer'/exp 6. 'foot'/exp 7. #5 AND #6 8. 'foot disease'/exp 9. 'diabetic foot'/exp 10. 'amputation'/exp 11. 'limb loss'/exp 12. #11 OR #11 13. #7 OR #8 OR #9 14. Incidence/exp 15. Prevalence/exp 16. #14 OR #15 17. 'ireland'/exp 18. 'irish (citizen)'/exp OR 'irish (citizen)' 19. #17 OR #18 20. 'diabetes mellitus'/exp For peripheral neuropathy: 21. #1 AND #16 AND #20 22. #21 AND #19 For peripheral artery disease: 23. #4 AND #16 AND #20 24. #23 AND #19 For diabetic foot ulcers: 25. #13 AND #16 AND #19 26. #13 AND #19 For amputations: 27. #12 AND #19 28. #12 AND #16 AND #20 29. #27 AND #19 Data management and study selection Software. Mendeley reference management system will be used as a bibliography manager, and Covidence ( https://www.covidence.org/ ) will be used for screening. The statistical Package Rev Man 5.4 will be used for meta-analysis. Study screening and selection. Results from each database will be imported into Mendeley, and at this stage any duplicates will be removed. Identified articles will then be exported to Covidence for title and abstract screening. This will be conducted independently by two reviewers. Any conflicts at this stage will be discussed, and where consensus cannot be reached, a third reviewer will be consulted. The same process will be employed for full text screening. Data extraction Data extraction will be conducted by one reviewer using a standardised data extraction drafted form in Microsoft Excel then rechecked by a second reviewer for accuracy. Reviewers will not extract data from any studies in which they were an author or co-author to prevent any conflict of interest or potential bias. It will include the following details: Author and year Study design Study setting e.g., hospital or community setting. Year(s) of data collection Length of follow up Population characteristics including participant age, gender, diabetes type and diabetes duration, sociodemographics, living urban or rural and mobility levels Outcomes of interest ○ Peripheral neuropathy ○ Peripheral artery disease ○ Foot ulcer ○ Lower extremity amputation (total, minor or major) How outcomes were measured e.g., was it from medical chart review, clinical assessment, self-reported. Quality assessment The most appropriate Joanna Briggs Institute (JBI) Critical Appraisal tool will be used to assess included studies methodological quality and establish the degree to which bias was addressed in the study’s design, conduct, and analysis 22 , 25 . To assess these parameters, the JBI checklists offer a series of questions to which ‘Yes’, ‘No’, ‘Unclear’, and ‘Not applicable’ are the provided answers. Assessment will be carried out by two reviewers independently, and where disagreements occur, a third reviewer will be consulted. Presenting and reporting of results A PRISMA flow diagram will be included to illustrate the study selection process. Tables will be used to allow for presentation of study characteristics, quality assessment scores and reporting of incidence and prevalence. In addition, data will be synthesised using a narrative synthesis approach to allow for comparison of similarities and the disparities between the findings of identified studies. This includes comparisons of results (prevalence and incidence of outcome of interest) between study settings, participant characteristics, measurement of outcomes, and methodological quality of included studies. In addition, if possible, subgroup comparison between national and regional studies will also be conducted. A meta-analysis will be performed if at least three publications reporting on the same outcome of interest, using similar definitions to identify the outcome, in a similar population of interest, with data collected within 10 years of each other are found. Meta-analyses will be used to calculate pooled incidence or prevalence estimates using a random-effects model, with the I 2 test used to examine heterogeneity across publications. Conclusion The systematic review outlined in this protocol will synthesise the existing evidence on incidence and prevalence of peripheral neuropathy, peripheral artery disease, ulceration, and amputation in people with diabetes residing in the Republic of Ireland. It is believed this review will help inform stakeholders on the burden of diabetic foot disease and help inform them on the appropriate use of resources to reduce the burden associated with diabetic foot disease in Ireland. Study status The protocol was registered prospectively with Prospero (CRD42023472904). Ethics Ethical approval is not required for a systematic review. Data availability Underlying data No data are associated with this article. Reporting guidelines OSF: PRISMA-P checklist for ‘Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol’. See: https://doi.org/10.17605/OSF.IO/THD78 Author contributions Sinead K: Conceptualization, Methodology, writing – Original Draft Preparation, writing – Review & Editing. Pallin JA: Methodology, writing – Final Draft Preparation, writing – Review & Editing. Lazzerini P: Methodology, Review & Editing. O’Keeffe L: Methodology, Review & Editing. Doherty A: : Methodology, Review & Editing. Buckley CM: Supervision, Writing – Review & Editing. SK is the guarantor. Faculty Opinions recommended References 1. Sun H, Saeedi P, Karuranga S, et al. : IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183 : 109119. PubMed Abstract | Publisher Full Text | Free Full Text 2. Saluja S, Anderson SG, Hambleton I, et al. : Foot ulceration and its association with mortality in diabetes mellitus: a meta-analysis. Diabet Med. 2020; 37 (2): 211–218. PubMed Abstract | Publisher Full Text 3. Ribu L, Birkeland K, Hanestad BR, et al. : A longitudinal study of patients with diabetes and foot ulcers and their Health-Related Quality of Life: wound healing and quality-of-life changes. J Diabetes Complications. 2008; 22 (6): 400–407. PubMed Abstract | Publisher Full Text 4. Sekhar MS, Thomas RR, Unnikrishnan MK, et al. : Impact of diabetic foot ulcer on Health-Related Quality of Life: a cross-sectional study. Semin Vasc Surg. 2015; 28 (3–4): 165–171. PubMed Abstract | Publisher Full Text 5. Brownrigg JRW, Davey J, Holt PJ, et al. : The association of ulceration of the foot with cardiovascular and all-Cause mortality in patients with diabetes: A meta-analysis. Diabetologia. 2012; 55 (11): 2906–2912. PubMed Abstract | Publisher Full Text 6. Kerr M, Barron E, Chadwick P, et al. : The cost of diabetic foot ulcers and amputations to the National Health Service in England. Diabet Med. 2019; 36 (8): 995–1002. PubMed Abstract | Publisher Full Text 7. Gillespie P, Kelly L, Hurley L, et al. : The effect of foot ulcers on costs of care for people with diabetes in Ireland. The Diabetic Foot Journal. 2014; 17 (3): 107–12. Reference Source 8. Gooday C, Hardeman W, Game F, et al. : A qualitative study to understand people’s experiences of living with Charcot neuroarthropathy. Diabet Med. 2022; 39 (6): e14784. PubMed Abstract | Publisher Full Text | Free Full Text 9. Lazzarini PA, Raspovic KM, Meloni M, et al. : A new declaration for feet’s sake: Halving the global diabetic foot disease burden from 2% to 1% with next generation care. Diabetes Metab Res Rev. 2024; 40 (3): e3747. PubMed Abstract | Publisher Full Text 10. Pecoraro RE, Reiber GE, Burgess EM: Pathways to diabetic limb amputation. basis for prevention. Diabetes Care. 1990; 13 (5): 513–521. PubMed Abstract | Publisher Full Text 11. Buckley CM, O’Farrell A, Canavan RJ, et al. : Trends in the incidence of lower extremity amputations in people with and without diabetes over a five-year period in the republic of Ireland. PLoS One. 2012; 7 (7): e41492. PubMed Abstract | Publisher Full Text | Free Full Text 12. Edmonds M, Manu C, Vas P: The current burden of diabetic foot disease. J Clin Orthop Trauma. 2021; 17 : 88–93. PubMed Abstract | Publisher Full Text | Free Full Text 13. Anderson SG, Shoo H, Saluja S, et al. : Social deprivation modifies the association between incident foot ulceration and mortality in type 1 and type 2 diabetes: a longitudinal study of a primary-care cohort. Diabetologia. 2018; 61 (4): 959–967. PubMed Abstract | Publisher Full Text | Free Full Text 14. Bus SA, Sacco ICN, Monteiro Soares M, et al. : Guidelines on the prevention of foot ulcers in persons with diabetes IWGDF 2023 update. Diabetes Metab Res Rev. 2024; 40 (3): e3651. PubMed Abstract | Publisher Full Text 15. Pankhurst CJW, Edmonds ME: Barriers to foot care in patients with diabetes as identified by healthcare professionals. Diabet Med. 2018; 35 (8): 1072–1077. PubMed Abstract | Publisher Full Text 16. O’Neill K, Riordan F, Racine E, et al. : Adoption and initial lmplementation of a national integrated care programme for diabetes: a realist evaluation. Int J Integr Care. 2022; 22 (3): 3. PubMed Abstract | Publisher Full Text | Free Full Text 17. Zhang P, Lu J, Jing Y, et al. : Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis †. Ann Med. 2017; 49 (2): 106–116. PubMed Abstract | Publisher Full Text 18. Zhang Y, Lazzarini PA, McPhail SM, et al. : Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care. 2020; 43 (5): 964–974. PubMed Abstract | Publisher Full Text 19. Diabetes Ireland: Diabetes Prevalence in Ireland. Published 2022. Accessed July 31, 2023. 20. Diabetes Ireland: Diabetes Footcare Statistics 2017-2021. 2022; Accessed July 31, 2023. 21. Page MJ, McKenzie JE, Bossuyt PM, et al. : The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372 : n71. PubMed Abstract | Publisher Full Text | Free Full Text 22. Aromataris E, Munn Z: JBI Manual for Evidence Synthesis. Joanna Briggs Institute. Publisher Full Text 23. Shamseer L, Moher D, Clarke M, et al. : Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015; 349 : g7647. PubMed Abstract | Publisher Full Text 24. Van Netten JJ, Bus SA, Apelqvist J, et al. : Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. 2024; 40 (3): e3654. PubMed Abstract | Publisher Full Text 25. Barker TH, Stone JC, Sears K, et al. : Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process. JBI Evid Synth. 2023; 21 (3): 478–493. PubMed Abstract | Publisher Full Text Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 03 Jan 2024 ADD YOUR COMMENT Comment Author details Author details 1 School of Public Health, University College Cork, Cork, County Cork, Ireland 2 Department of Endocrinology, Bantry Hospital, Bantry, Cork, Ireland 3 Department of General Practice, University College Cork, Cork, County Cork, Ireland 4 School of Public Health and Social Work,, Queensland University of Technology, Brisbane, Queensland, Australia 5 Allied Health Research Collaborative, The Prince Charles Hospital, Brisbane, Queensland, Australia Sinead Kavanagh Roles: Conceptualization, Methodology, Writing – Original Draft Preparation, Writing – Review & Editing Jennifer A. Pallin Roles: Conceptualization, Methodology, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing Ann Sinead Doherty Roles: Methodology, Supervision, Writing – Review & Editing Peter Lazzarini Roles: Methodology Linda O'Keeffe Roles: Methodology, Writing – Review & Editing Claire M Buckley Roles: Conceptualization, Methodology, Supervision, Writing – Review & Editing Competing interests No competing interests were disclosed. Grant information Health Research Board Ireland [CDA-2019-007]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Article Versions (2) version 2 Revised Published: 21 Aug 2024, 7:1 https://doi.org/10.12688/hrbopenres.13823.2 version 1 Published: 03 Jan 2024, 7:1 https://doi.org/10.12688/hrbopenres.13823.1 Copyright © 2024 Kavanagh S et al . This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Download Export To Sciwheel Bibtex EndNote ProCite Ref. Manager (RIS) Sente metrics VIEWS $counts.viewCount downloads Citations open_in_new 0 open_in_new 0 open_in_new SEE MORE DETAILS CITE how to cite this article Kavanagh S, Pallin JA, Doherty AS et al. Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.12688/hrbopenres.13823.2 ) NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS track receive updates on this article Track an article to receive email alerts on any updates to this article. TRACK THIS ARTICLE Share Open Peer Review Current Reviewer Status: ? Key to Reviewer Statuses VIEW HIDE Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Version 2 VERSION 2 PUBLISHED 21 Aug 2024 Revised Views 0 Cite How to cite this report: Abbas ZG. Reviewer Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15325.r42852 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v2#referee-response-42852 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 13 Nov 2024 Zulfiqarali G Abbas , Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania Approved with Reservations VIEWS 0 https://doi.org/10.21956/hrbopenres.15325.r42852 Your Report Title: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland Strengths Clear research aims and relevance: The protocol ... Continue reading READ ALL Your Report Title: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland Strengths Clear research aims and relevance: The protocol addresses a significant gap in diabetic foot disease epidemiology in Ireland, given the absence of a national diabetes registry. By providing prevalence and incidence estimates, this review could inform stakeholders about the need for targeted interventions. Comprehensive Methodology: The protocol follows the PRISMA-P guidelines, with a structured approach to data collection, screening, and analysis. Detailed inclusion and exclusion criteria: The well-defined criteria for population, settings, and study design ensure consistency and clarity in study selection, minimising bias. Appropriate Data Extraction and Quality Assessment: The use of the Joanna Briggs Institute (JBI) tool for critical appraisal shows an attempt to ensure methodological rigor. The protocol also accounts for relevant factors like sociodemographic, urban versus rural location, and patient mobility. Limitations and Areas for Improvement Lack of Specific Quality Assessment Tools: While the protocol mentions the use of JBI tools, it doesn’t specify the exact tools for different study designs, which could limit clarity. Limited Scope in Search Strategy: While the Coco Pop framework is used, the search strategy could be expanded to include more databases to ensure broader coverage. Limiting the search to PubMed, EMBASE, and Lenus might overlook grey literature that may not be present in mainstream databases. Ambiguity in Meta-Analysis Plans: Although a meta-analysis is proposed if criteria are met, there is no indication of how data heterogeneity will be managed or the potential use of meta-regression to account for varying study characteristics. Justification for Excluding Single-Centre Studies: Excluding single-centre studies may limit the review’s comprehensiveness. Including a rationale for this decision would strengthen the protocol. Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Consultant Physician, Diabetologist and diabetic related foot complications I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Abbas ZG. Reviewer Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15325.r42852 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v2#referee-response-42852 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Moore Z. Reviewer Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15325.r42034 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v2#referee-response-42034 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 27 Aug 2024 Zena Moore , RCSI University of Medicine and Health Sciences, Dublin, Ireland Approved VIEWS 0 https://doi.org/10.21956/hrbopenres.15325.r42034 I have no ... Continue reading READ ALL I have no new comments to make Competing Interests: No competing interests were disclosed. Reviewer Expertise: Systematic review methods. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Moore Z. Reviewer Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15325.r42034 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v2#referee-response-42034 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Respond or Comment COMMENT ON THIS REPORT Version 1 VERSION 1 PUBLISHED 03 Jan 2024 Views 0 Cite How to cite this report: Heald AH. Reviewer Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15133.r39652 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v1#referee-response-39652 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 03 Jun 2024 Adrian H Heald , Salford Royal Hospital, University of Manchester, Manchester, UK Approved with Reservations VIEWS 0 https://doi.org/10.21956/hrbopenres.15133.r39652 Thank you for giving me the opportunity to review this protocol. I support the proposal. The authors are very modest about the implications for the findings of this excellent piece of work. Please can the abstract and ... Continue reading READ ALL Thank you for giving me the opportunity to review this protocol. I support the proposal. The authors are very modest about the implications for the findings of this excellent piece of work. Please can the abstract and overall conclusion reflect the international i,e global relevance of this piece of work In relation to potential small improvements, re search terms it is important that 3 things be considered: Sociodemographic situation- [Ref-1,2] Urban vs rural location- [Ref-3] Mobility-[Ref-4] The relevant papers (as above) to this that should be included in the Introduction Otherwise I am happy with the paper Dr Adrian Heald Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Yes References 1. Saluja S, Anderson SG, Hambleton I, Shoo H, et al.: Foot ulceration and its association with mortality in diabetes mellitus: a meta-analysis. Diabet Med . 2020; 37 (2): 211-218 PubMed Abstract | Publisher Full Text 2. Anderson SG, Shoo H, Saluja S, Anderson CD, et al.: Social deprivation modifies the association between incident foot ulceration and mortality in type 1 and type 2 diabetes: a longitudinal study of a primary-care cohort. Diabetologia . 2018; 61 (4): 959-967 PubMed Abstract | Publisher Full Text 3. Stedman M, Lunt M, Davies M, Fulton-McAlister E, et al.: Controlling antibiotic usage-A national analysis of General Practitioner/Family Doctor practices links overall antibiotic levels to demography, geography, comorbidity factors with local discretionary prescribing choices. Int J Clin Pract . 2020; 74 (8): e13515 PubMed Abstract | Publisher Full Text 4. Orlando G, Reeves ND, Boulton AJM, Ireland A, et al.: Sedentary behaviour is an independent predictor of diabetic foot ulcer development: An 8-year prospective study. Diabetes Res Clin Pract . 2021; 177 : 108877 PubMed Abstract | Publisher Full Text Competing Interests: No competing interests were disclosed. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Heald AH. Reviewer Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15133.r39652 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v1#referee-response-39652 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 23 Aug 2024 Jennifer Pallin , School of Public Health, University College Cork, Cork, Ireland 23 Aug 2024 Author Response Dear Dr Heald, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. As a result, revisions have been made, and points raised have been ... Continue reading Dear Dr Heald, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. As a result, revisions have been made, and points raised have been addressed below. Please can the abstract and overall conclusion reflect the international i,e global relevance of this piece of work We have updated the abstract and introduction to emphasize the impact diabetic foot disease can have on individuals and health systems globally. Based on your recommendations we have included reference number 1 and 2 to support these points. However, we have not included reference 3 and 4, as we do not agree they strengthen the quality of the introduction section. The aim of reference 3 was to quantify the impact of different factors on levels of antibiotic prescribing choices by GP/family doctors. While we acknowledge this is an important area, particularly for people experiencing diabetic foot ulcers and infections, we do not believe inclusion of this paper strengthens the quality of the introduction section. The aim of reference 4 was to prospectively explore the association between sedentary time (SED-time) and the development of diabetic foot ulcer (DFU) in people with diabetic peripheral neuropathy (DPN). While we acknowledge risk factors for diabetic foot ulcer onset is an important area for consider, we do not believe inclusion of this paper strengthens the quality of the introduction section. However, we acknowledge your point that we should emphasize the global relevance of this piece of work, and so we have included other internationally relevant pieces of work. We will also take this advice on board when writing the results paper. In relation to potential small improvements, re search terms it is important that 3 things be considered: Sociodemographic situation- [Ref-1,2] Urban vs rural location- [Ref-3] Mobility-[Ref-4] We thank the reviewer for the suggestion of additional factors to consider. As we have already completed the search using the terms indicated in version 1 of the protocol we have opted not to repeat the search with these as aspects as search terms. Instead, we have included additional points for data extraction, where information on these factors is available. Dear Dr Heald, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. As a result, revisions have been made, and points raised have been addressed below. Please can the abstract and overall conclusion reflect the international i,e global relevance of this piece of work We have updated the abstract and introduction to emphasize the impact diabetic foot disease can have on individuals and health systems globally. Based on your recommendations we have included reference number 1 and 2 to support these points. However, we have not included reference 3 and 4, as we do not agree they strengthen the quality of the introduction section. The aim of reference 3 was to quantify the impact of different factors on levels of antibiotic prescribing choices by GP/family doctors. While we acknowledge this is an important area, particularly for people experiencing diabetic foot ulcers and infections, we do not believe inclusion of this paper strengthens the quality of the introduction section. The aim of reference 4 was to prospectively explore the association between sedentary time (SED-time) and the development of diabetic foot ulcer (DFU) in people with diabetic peripheral neuropathy (DPN). While we acknowledge risk factors for diabetic foot ulcer onset is an important area for consider, we do not believe inclusion of this paper strengthens the quality of the introduction section. However, we acknowledge your point that we should emphasize the global relevance of this piece of work, and so we have included other internationally relevant pieces of work. We will also take this advice on board when writing the results paper. In relation to potential small improvements, re search terms it is important that 3 things be considered: Sociodemographic situation- [Ref-1,2] Urban vs rural location- [Ref-3] Mobility-[Ref-4] We thank the reviewer for the suggestion of additional factors to consider. As we have already completed the search using the terms indicated in version 1 of the protocol we have opted not to repeat the search with these as aspects as search terms. Instead, we have included additional points for data extraction, where information on these factors is available. Competing Interests: No competing interests were disclosed. Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 23 Aug 2024 Jennifer Pallin , School of Public Health, University College Cork, Cork, Ireland 23 Aug 2024 Author Response Dear Dr Heald, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. As a result, revisions have been made, and points raised have been ... Continue reading Dear Dr Heald, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. As a result, revisions have been made, and points raised have been addressed below. Please can the abstract and overall conclusion reflect the international i,e global relevance of this piece of work We have updated the abstract and introduction to emphasize the impact diabetic foot disease can have on individuals and health systems globally. Based on your recommendations we have included reference number 1 and 2 to support these points. However, we have not included reference 3 and 4, as we do not agree they strengthen the quality of the introduction section. The aim of reference 3 was to quantify the impact of different factors on levels of antibiotic prescribing choices by GP/family doctors. While we acknowledge this is an important area, particularly for people experiencing diabetic foot ulcers and infections, we do not believe inclusion of this paper strengthens the quality of the introduction section. The aim of reference 4 was to prospectively explore the association between sedentary time (SED-time) and the development of diabetic foot ulcer (DFU) in people with diabetic peripheral neuropathy (DPN). While we acknowledge risk factors for diabetic foot ulcer onset is an important area for consider, we do not believe inclusion of this paper strengthens the quality of the introduction section. However, we acknowledge your point that we should emphasize the global relevance of this piece of work, and so we have included other internationally relevant pieces of work. We will also take this advice on board when writing the results paper. In relation to potential small improvements, re search terms it is important that 3 things be considered: Sociodemographic situation- [Ref-1,2] Urban vs rural location- [Ref-3] Mobility-[Ref-4] We thank the reviewer for the suggestion of additional factors to consider. As we have already completed the search using the terms indicated in version 1 of the protocol we have opted not to repeat the search with these as aspects as search terms. Instead, we have included additional points for data extraction, where information on these factors is available. Dear Dr Heald, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. As a result, revisions have been made, and points raised have been addressed below. Please can the abstract and overall conclusion reflect the international i,e global relevance of this piece of work We have updated the abstract and introduction to emphasize the impact diabetic foot disease can have on individuals and health systems globally. Based on your recommendations we have included reference number 1 and 2 to support these points. However, we have not included reference 3 and 4, as we do not agree they strengthen the quality of the introduction section. The aim of reference 3 was to quantify the impact of different factors on levels of antibiotic prescribing choices by GP/family doctors. While we acknowledge this is an important area, particularly for people experiencing diabetic foot ulcers and infections, we do not believe inclusion of this paper strengthens the quality of the introduction section. The aim of reference 4 was to prospectively explore the association between sedentary time (SED-time) and the development of diabetic foot ulcer (DFU) in people with diabetic peripheral neuropathy (DPN). While we acknowledge risk factors for diabetic foot ulcer onset is an important area for consider, we do not believe inclusion of this paper strengthens the quality of the introduction section. However, we acknowledge your point that we should emphasize the global relevance of this piece of work, and so we have included other internationally relevant pieces of work. We will also take this advice on board when writing the results paper. In relation to potential small improvements, re search terms it is important that 3 things be considered: Sociodemographic situation- [Ref-1,2] Urban vs rural location- [Ref-3] Mobility-[Ref-4] We thank the reviewer for the suggestion of additional factors to consider. As we have already completed the search using the terms indicated in version 1 of the protocol we have opted not to repeat the search with these as aspects as search terms. Instead, we have included additional points for data extraction, where information on these factors is available. Competing Interests: No competing interests were disclosed. Close Report a concern COMMENT ON THIS REPORT Views 0 Cite How to cite this report: Moore Z. Reviewer Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15133.r38450 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v1#referee-response-38450 NOTE: it is important to ensure the information in square brackets after the title is included in this citation. Close Copy Citation Details Reviewer Report 22 Mar 2024 Zena Moore , RCSI University of Medicine and Health Sciences, Dublin, Ireland Approved VIEWS 0 https://doi.org/10.21956/hrbopenres.15133.r38450 Many thanks for this protocol for a very important systematic review. The methods are in general clearly described, however, there are 2 minor issues for clarification. 1. In terms of data extraction, given that you are interested in incidence as ... Continue reading READ ALL Many thanks for this protocol for a very important systematic review. The methods are in general clearly described, however, there are 2 minor issues for clarification. 1. In terms of data extraction, given that you are interested in incidence as well as prevalence, length of patient follow up should be extracted, where this information is available. 2. In terms of quality appraisal, you are vague regarding which exact quality appraisal tool(s) will be employed, I think you could provide some concrete examples, given that you have said that the following study designs are eligible for inclusion: Prospective and retrospective cross-sectional, case-control or cohort studies. Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Yes Competing Interests: No competing interests were disclosed. Reviewer Expertise: Systematic review methods. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. Close READ LESS CITE CITE HOW TO CITE THIS REPORT Moore Z. Reviewer Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15133.r38450 ) The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v1#referee-response-38450 NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article. COPY CITATION DETAILS Report a concern Author Response 23 Aug 2024 Jennifer Pallin , School of Public Health, University College Cork, Cork, Ireland 23 Aug 2024 Author Response Dear Prof Moore, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. Also, thank you for approving our protocol. However, based on your ... Continue reading Dear Prof Moore, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. Also, thank you for approving our protocol. However, based on your feedback, revisions have been made and points raised have been addressed below. In terms of data extraction, given that you are interested in incidence as well as prevalence, length of patient follow up should be extracted, where this information is available Based on your feedback, we have included length of follow-up in data extraction. We have ammended the protocol to reflect this. In terms of quality appraisal, you are vague regarding which exact quality appraisal tool(s) will be employed, I think you could provide some concrete examples, given that you have said that the following study designs are eligible for inclusion: Prospective and retrospective cross-sectional, case-control or cohort studies. Regarding quality appraisal, we acknowledge we were vague on exactly what JBI quality appraisal tool we would use. We have taken this feedback on board, and will make sure it is clearly stated in the final systematic review publication. Dear Prof Moore, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. Also, thank you for approving our protocol. However, based on your feedback, revisions have been made and points raised have been addressed below. In terms of data extraction, given that you are interested in incidence as well as prevalence, length of patient follow up should be extracted, where this information is available Based on your feedback, we have included length of follow-up in data extraction. We have ammended the protocol to reflect this. In terms of quality appraisal, you are vague regarding which exact quality appraisal tool(s) will be employed, I think you could provide some concrete examples, given that you have said that the following study designs are eligible for inclusion: Prospective and retrospective cross-sectional, case-control or cohort studies. Regarding quality appraisal, we acknowledge we were vague on exactly what JBI quality appraisal tool we would use. We have taken this feedback on board, and will make sure it is clearly stated in the final systematic review publication. Competing Interests: No competing interests were disclosed. Close Report a concern Respond or Comment COMMENTS ON THIS REPORT Author Response 23 Aug 2024 Jennifer Pallin , School of Public Health, University College Cork, Cork, Ireland 23 Aug 2024 Author Response Dear Prof Moore, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. Also, thank you for approving our protocol. However, based on your ... Continue reading Dear Prof Moore, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. Also, thank you for approving our protocol. However, based on your feedback, revisions have been made and points raised have been addressed below. In terms of data extraction, given that you are interested in incidence as well as prevalence, length of patient follow up should be extracted, where this information is available Based on your feedback, we have included length of follow-up in data extraction. We have ammended the protocol to reflect this. In terms of quality appraisal, you are vague regarding which exact quality appraisal tool(s) will be employed, I think you could provide some concrete examples, given that you have said that the following study designs are eligible for inclusion: Prospective and retrospective cross-sectional, case-control or cohort studies. Regarding quality appraisal, we acknowledge we were vague on exactly what JBI quality appraisal tool we would use. We have taken this feedback on board, and will make sure it is clearly stated in the final systematic review publication. Dear Prof Moore, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. Also, thank you for approving our protocol. However, based on your feedback, revisions have been made and points raised have been addressed below. In terms of data extraction, given that you are interested in incidence as well as prevalence, length of patient follow up should be extracted, where this information is available Based on your feedback, we have included length of follow-up in data extraction. We have ammended the protocol to reflect this. In terms of quality appraisal, you are vague regarding which exact quality appraisal tool(s) will be employed, I think you could provide some concrete examples, given that you have said that the following study designs are eligible for inclusion: Prospective and retrospective cross-sectional, case-control or cohort studies. Regarding quality appraisal, we acknowledge we were vague on exactly what JBI quality appraisal tool we would use. We have taken this feedback on board, and will make sure it is clearly stated in the final systematic review publication. Competing Interests: No competing interests were disclosed. Close Report a concern COMMENT ON THIS REPORT Comments on this article Comments (0) Version 2 VERSION 2 PUBLISHED 03 Jan 2024 ADD YOUR COMMENT Comment keyboard_arrow_left keyboard_arrow_right Open Peer Review Reviewer Status info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Reviewer Reports Invited Reviewers 1 2 3 Version 2 (revision) 21 Aug 24 read read Version 1 03 Jan 24 read read Zena Moore , RCSI University of Medicine and Health Sciences, Dublin, Ireland Adrian H Heald , University of Manchester, Manchester, UK Zulfiqarali G Abbas , Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania Comments on this article All Comments (0) Add a comment Sign up for content alerts Sign Up You are now signed up to receive this alert keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Abbas Z. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 13 Nov 2024 | for Version 2 Zulfiqarali G Abbas , Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania 0 Views copyright © 2024 Abbas Z. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Your Report Title: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland Strengths Clear research aims and relevance: The protocol addresses a significant gap in diabetic foot disease epidemiology in Ireland, given the absence of a national diabetes registry. By providing prevalence and incidence estimates, this review could inform stakeholders about the need for targeted interventions. Comprehensive Methodology: The protocol follows the PRISMA-P guidelines, with a structured approach to data collection, screening, and analysis. Detailed inclusion and exclusion criteria: The well-defined criteria for population, settings, and study design ensure consistency and clarity in study selection, minimising bias. Appropriate Data Extraction and Quality Assessment: The use of the Joanna Briggs Institute (JBI) tool for critical appraisal shows an attempt to ensure methodological rigor. The protocol also accounts for relevant factors like sociodemographic, urban versus rural location, and patient mobility. Limitations and Areas for Improvement Lack of Specific Quality Assessment Tools: While the protocol mentions the use of JBI tools, it doesn’t specify the exact tools for different study designs, which could limit clarity. Limited Scope in Search Strategy: While the Coco Pop framework is used, the search strategy could be expanded to include more databases to ensure broader coverage. Limiting the search to PubMed, EMBASE, and Lenus might overlook grey literature that may not be present in mainstream databases. Ambiguity in Meta-Analysis Plans: Although a meta-analysis is proposed if criteria are met, there is no indication of how data heterogeneity will be managed or the potential use of meta-regression to account for varying study characteristics. Justification for Excluding Single-Centre Studies: Excluding single-centre studies may limit the review’s comprehensiveness. Including a rationale for this decision would strengthen the protocol. Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Consultant Physician, Diabetologist and diabetic related foot complications I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (0) Abbas ZG. Peer Review Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15325.r42852) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v2#referee-response-42852 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Moore Z. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 27 Aug 2024 | for Version 2 Zena Moore , RCSI University of Medicine and Health Sciences, Dublin, Ireland 0 Views copyright © 2024 Moore Z. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (0) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions I have no new comments to make Competing Interests No competing interests were disclosed. Reviewer Expertise Systematic review methods. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (0) Moore Z. Peer Review Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15325.r42034) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v2#referee-response-42034 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Heald A. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 03 Jun 2024 | for Version 1 Adrian H Heald , Salford Royal Hospital, University of Manchester, Manchester, UK 0 Views copyright © 2024 Heald A. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved With Reservations info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Thank you for giving me the opportunity to review this protocol. I support the proposal. The authors are very modest about the implications for the findings of this excellent piece of work. Please can the abstract and overall conclusion reflect the international i,e global relevance of this piece of work In relation to potential small improvements, re search terms it is important that 3 things be considered: Sociodemographic situation- [Ref-1,2] Urban vs rural location- [Ref-3] Mobility-[Ref-4] The relevant papers (as above) to this that should be included in the Introduction Otherwise I am happy with the paper Dr Adrian Heald Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Yes References 1. Saluja S, Anderson SG, Hambleton I, Shoo H, et al.: Foot ulceration and its association with mortality in diabetes mellitus: a meta-analysis. Diabet Med . 2020; 37 (2): 211-218 PubMed Abstract | Publisher Full Text 2. Anderson SG, Shoo H, Saluja S, Anderson CD, et al.: Social deprivation modifies the association between incident foot ulceration and mortality in type 1 and type 2 diabetes: a longitudinal study of a primary-care cohort. Diabetologia . 2018; 61 (4): 959-967 PubMed Abstract | Publisher Full Text 3. Stedman M, Lunt M, Davies M, Fulton-McAlister E, et al.: Controlling antibiotic usage-A national analysis of General Practitioner/Family Doctor practices links overall antibiotic levels to demography, geography, comorbidity factors with local discretionary prescribing choices. Int J Clin Pract . 2020; 74 (8): e13515 PubMed Abstract | Publisher Full Text 4. Orlando G, Reeves ND, Boulton AJM, Ireland A, et al.: Sedentary behaviour is an independent predictor of diabetic foot ulcer development: An 8-year prospective study. Diabetes Res Clin Pract . 2021; 177 : 108877 PubMed Abstract | Publisher Full Text Competing Interests No competing interests were disclosed. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above. reply Respond to this report Responses (1) Author Response 23 Aug 2024 Jennifer Pallin, School of Public Health, University College Cork, Cork, Ireland Dear Dr Heald, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. As a result, revisions have been made, and points raised have been addressed below. Please can the abstract and overall conclusion reflect the international i,e global relevance of this piece of work We have updated the abstract and introduction to emphasize the impact diabetic foot disease can have on individuals and health systems globally. Based on your recommendations we have included reference number 1 and 2 to support these points. However, we have not included reference 3 and 4, as we do not agree they strengthen the quality of the introduction section. The aim of reference 3 was to quantify the impact of different factors on levels of antibiotic prescribing choices by GP/family doctors. While we acknowledge this is an important area, particularly for people experiencing diabetic foot ulcers and infections, we do not believe inclusion of this paper strengthens the quality of the introduction section. The aim of reference 4 was to prospectively explore the association between sedentary time (SED-time) and the development of diabetic foot ulcer (DFU) in people with diabetic peripheral neuropathy (DPN). While we acknowledge risk factors for diabetic foot ulcer onset is an important area for consider, we do not believe inclusion of this paper strengthens the quality of the introduction section. However, we acknowledge your point that we should emphasize the global relevance of this piece of work, and so we have included other internationally relevant pieces of work. We will also take this advice on board when writing the results paper. In relation to potential small improvements, re search terms it is important that 3 things be considered: Sociodemographic situation- [Ref-1,2] Urban vs rural location- [Ref-3] Mobility-[Ref-4] We thank the reviewer for the suggestion of additional factors to consider. As we have already completed the search using the terms indicated in version 1 of the protocol we have opted not to repeat the search with these as aspects as search terms. Instead, we have included additional points for data extraction, where information on these factors is available. View more View less Competing Interests No competing interests were disclosed. reply Respond Report a concern Heald AH. Peer Review Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15133.r39652) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v1#referee-response-39652 keyboard_arrow_left Back to all reports Reviewer Report 0 Views copyright © 2024 Moore Z. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 22 Mar 2024 | for Version 1 Zena Moore , RCSI University of Medicine and Health Sciences, Dublin, Ireland 0 Views copyright © 2024 Moore Z. This is an open access peer review report distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. format_quote Cite this report speaker_notes Responses (1) Approved info_outline Alongside their report, reviewers assign a status to the article: Approved The paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved Fundamental flaws in the paper seriously undermine the findings and conclusions Many thanks for this protocol for a very important systematic review. The methods are in general clearly described, however, there are 2 minor issues for clarification. 1. In terms of data extraction, given that you are interested in incidence as well as prevalence, length of patient follow up should be extracted, where this information is available. 2. In terms of quality appraisal, you are vague regarding which exact quality appraisal tool(s) will be employed, I think you could provide some concrete examples, given that you have said that the following study designs are eligible for inclusion: Prospective and retrospective cross-sectional, case-control or cohort studies. Is the rationale for, and objectives of, the study clearly described? Yes Is the study design appropriate for the research question? Yes Are sufficient details of the methods provided to allow replication by others? Yes Are the datasets clearly presented in a useable and accessible format? Yes Competing Interests No competing interests were disclosed. Reviewer Expertise Systematic review methods. I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard. reply Respond to this report Responses (1) Author Response 23 Aug 2024 Jennifer Pallin, School of Public Health, University College Cork, Cork, Ireland Dear Prof Moore, Thank you for taking the time for reviewing our protocol, and for your constructive feedback. Also, thank you for approving our protocol. However, based on your feedback, revisions have been made and points raised have been addressed below. In terms of data extraction, given that you are interested in incidence as well as prevalence, length of patient follow up should be extracted, where this information is available Based on your feedback, we have included length of follow-up in data extraction. We have ammended the protocol to reflect this. In terms of quality appraisal, you are vague regarding which exact quality appraisal tool(s) will be employed, I think you could provide some concrete examples, given that you have said that the following study designs are eligible for inclusion: Prospective and retrospective cross-sectional, case-control or cohort studies. Regarding quality appraisal, we acknowledge we were vague on exactly what JBI quality appraisal tool we would use. We have taken this feedback on board, and will make sure it is clearly stated in the final systematic review publication. View more View less Competing Interests No competing interests were disclosed. reply Respond Report a concern Moore Z. Peer Review Report For: Prevalence and incidence of peripheral neuropathy, peripheral artery disease, foot disease, and lower extremity amputation in people with diabetes in Ireland; a systematic review protocol. [version 2; peer review: 1 approved, 2 approved with reservations] . HRB Open Res 2024, 7 :1 ( https://doi.org/10.21956/hrbopenres.15133.r38450) NOTE: it is important to ensure the information in square brackets after the title is included in this citation. The direct URL for this report is: https://hrbopenresearch.org/articles/7-1/v1#referee-response-38450 Alongside their report, reviewers assign a status to the article: Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions Adjust parameters to alter display View on desktop for interactive features Includes Interactive Elements View on desktop for interactive features Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Stay Updated Sign up for content alerts and receive a weekly or monthly email with all newly published articles Register with HRB Open Research Already registered? Sign in Not now, thanks close PLEASE NOTE If you are an AUTHOR of this article, please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a “User Comment”. If you are a REVIEWER of this article, please check that you have signed in with the account associated with this article and then go to your account to submit your report, please do not post your review here. If you do not have access to your original account, please contact us . All commenters must hold a formal affiliation as per our Policies . The information that you give us will be displayed next to your comment. User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the User Comment Terms and Conditions . Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available. I accept the User Comment Terms and Conditions Please confirm that you accept the User Comment Terms and Conditions. Affiliation ✕ refresh Please enter your institution. Note: To add your institution or organisation, start typing the name and then select the correct name from the list. Where applicable, the name will appear in both the original language and in English. Do not paste in the name. If the name does not appear in the drop-down list, we will display the information you have entered. ✕ refresh Country/Region * USA UK Canada China France Germany Afghanistan Aland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Cook Islands Costa Rica Cote d'Ivoire Croatia Cuba Cyprus Czech Republic Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands Faroe Islands Federated States of Micronesia Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and Mcdonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo (Serbia and Montenegro) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Minor Outlying Islands of the United States Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Korea North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territory Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Helena Saint Kitts and Nevis Saint Lucia Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Is South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand The Gambia The Netherlands Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu UK USA Uganda Ukraine United Arab Emirates United States Virgin Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Wallis and Futuna West Bank and Gaza Strip Western Sahara Yemen Zambia Zimbabwe Please select your country/region. You must enter a comment. Competing Interests Please disclose any competing interests that might be construed to influence your judgment of the article's or peer review report's validity or importance. Competing Interests Policy Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: Examples of 'Non-Financial Competing Interests' Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper. You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors. You are a close professional associate of any of the authors (e.g. scientific mentor, recent student). You work at the same institute as any of the authors. You hope/expect to benefit (e.g. favour or employment) as a result of your submission. You are an Editor for the journal in which the article is published. Examples of 'Financial Competing Interests' You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements. You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors. You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on. Please state your competing interests The comment has been saved. An error has occurred. Please try again. Cancel Post var lTitle = "Prevalence and incidence of peripheral neuropathy,...".replace("'", ''); var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://hrbopenresearch.org/articles/7-1/v2" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by '); var deliciousUrl = "https://del.icio.us/post?url=https://hrbopenresearch.org/articles/7-1/v2&title=" + encodeURIComponent(lTitle); var redditUrl = "http://reddit.com/submit?url=https://hrbopenresearch.org/articles/7-1/v2" + "&title=" + encodeURIComponent(lTitle); linkedInUrl += encodeURIComponent('Kavanagh S et al.'); var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; var addthis_config = { ui_offset_top: offsetTop, services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com", services_custom : [ { name: "LinkedIn", url: linkedInUrl, icon:"/img/icon/at_linkedin.svg" }, { name: "Mendeley", url: "http://www.mendeley.com/import/?url=https://hrbopenresearch.org/articles/7-1/v2/mendeley", icon:"/img/icon/at_mendeley.svg" }, { name: "Reddit", url: redditUrl, icon:"/img/icon/at_reddit.svg" }, ] }; var addthis_share = { url: "https://hrbopenresearch.org/articles/7-1", templates : { twitter : "Prevalence and incidence of peripheral neuropathy, peripheral.... Kavanagh S et al., published by " + "@HRBOpenRes" + ", https://hrbopenresearch.org/articles/7-1/v2" } }; if (typeof(addthis) != "undefined"){ addthis.addEventListener('addthis.ready', checkCount); addthis.addEventListener('addthis.menu.share', checkCount); } $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter); $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url); $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url); $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url); $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url); function checkCount(){ setTimeout(function(){ $(".addthis_button_expanded").each(function(){ var count = $(this).text(); if (count !== "" && count != "0") $(this).removeClass("is-hidden"); else $(this).addClass("is-hidden"); }); }, 1000); } close How to cite this report {{reportCitation}} Cancel Copy Citation Details $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');}); $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');}); $.get("/articles/acj/13823/15325") new F1000.Clipboard(); new F1000.ThesaurusTermsDisplay("articles", "article", "15325"); $(document).ready(function() { $( "#frame1" ).on('load', function() { var mydiv = $(this).contents().find("div"); var h = mydiv.height(); console.log(h) }); var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"), titleLivingFigure = tooltipLivingFigure.attr("title"); tooltipLivingFigure.simpletip({ fixed: true, position: ["-115", "30"], baseClass: 'small-tooltip', content:titleLivingFigure + " " }); tooltipLivingFigure.removeAttr("title"); $("body").on("click", ".cite-living-figure", function(e) { e.preventDefault(); var ref = $(this).attr("data-ref"); $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200); }); $("body").on("click", ".close-cite-living-figure", function(e) { e.preventDefault(); $(this).closest(".popup-window-wrapper").fadeOut(200); }); $(document).on("mouseup", function(e) { var metricsContainer = $(".article-metrics-popover-wrapper"); if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) { $(".article-metrics-close-button").click(); } }); var articleId = $('#articleId').val(); if($("#main-article-count-box").attachArticleMetrics) { $("#main-article-count-box").attachArticleMetrics(articleId, { articleMetricsView: true }); } }); var figshareWidget = $(".new_figshare_widget"); if (figshareWidget.length > 0) { window.figshare.load("f1000", function(Widget) { // Select a tag/tags defined in your page. In this tag we will place the widget. _.map(figshareWidget, function(el){ var widget = new Widget({ articleId: $(el).attr("figshare_articleId") //height:300 // this is the height of the viewer part. [Default: 550] }); widget.initialize(); // initialize the widget widget.mount(el); // mount it in a tag that's on your page // this will save the widget on the global scope for later use from // your JS scripts. This line is optional. //window.widget = widget; }); }); } close Error Close Add Reset F1000.MICROSERVICES.AFFILIATION = ''; $(document).ready(function () { $('.js-affiliations-form').each((index, form) => { new AffiliationForm({ formId: form.id, institutionErrorSelector: '.comment-enter-institution', departmentErrorSelector: '.comment-enter-department', placeSelector: '.js-add-comment-place', stateSelector: '.js-add-comment-state', zipCodeSelector: '.js-add-comment-zipcode', countrySelector: '.js-add-comment-country', countryErrorSelector: '.comment-enter-country', }); }); }); $(document).ready(function () { var reportIds = { "38148": 0, "38149": 0, "38150": 0, "38151": 0, "38152": 0, "42505": 0, "38153": 0, "42506": 0, "38154": 0, "42507": 0, "38155": 0, "42508": 0, "38156": 0, "42509": 0, "38157": 0, "42510": 0, "42511": 0, "42512": 0, "42513": 0, "42514": 0, "42388": 0, "42389": 0, "42390": 0, "42391": 0, "42392": 0, "42393": 0, "42394": 0, "42395": 0, "42396": 0, "42397": 0, "42661": 0, "42662": 0, "42663": 0, "42664": 0, "42665": 0, "42666": 0, "42667": 0, "42668": 0, "42669": 0, "42670": 0, "42033": 0, "38449": 0, "42034": 22, "38450": 60, "38451": 0, "38452": 0, "38453": 0, "38454": 0, "38455": 0, "38456": 0, "38457": 0, "38458": 0, "39372": 0, "39373": 0, "39374": 0, "39375": 0, "39376": 0, "39377": 0, "39378": 0, "39379": 0, "39380": 0, "39381": 0, "42845": 0, "42846": 0, "42847": 0, "42848": 0, "42849": 0, "42850": 0, "42851": 0, "42852": 22, "39652": 57, "42853": 0, "39653": 0, "42854": 0, "39654": 0, "39655": 0, "39656": 0, "39657": 0, "39658": 0, "39659": 0, "39660": 0, }; $(".referee-response-container,.js-referee-report").each(function(index, el) { var reportId = $(el).attr("data-reportid"), reportCount = reportIds[reportId] || 0; $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount); }); var uuidInput = $("#article_uuid"), oldUUId = uuidInput.val(), newUUId = "ee90d2df-a8b9-4e87-98e8-0f233d385383"; uuidInput.val(newUUId); $("a[href*='article_uuid=']").each(function(index, el) { var newHref = $(el).attr("href").replace(oldUUId, newUUId); $(el).attr("href", newHref); }); }); Are you a HRB-funded researcher? Submission to HRB Open Research is open to all HRB grantholders or people working on a HRB-funded/co-funded grant on or since 1 January 2017. Sign up for information about developments, publishing and publications from HRB Open Research. First Name * You must provide your first name Last Name * You must provide your last name Email * You must provide a valid email address Institution You must provide an institution. Submit Thank you! We'll keep you updated on any major new updates to HRB Open Research HRB Open Research Browse How to Publish About Contact RSS Cookie Notice Privacy Notice Legal Submit Your Research © F1000 Research Limited and its licensors ISSN 2515-4826 | Legal background var F1000platform = new F1000.Platform({ name: "hrb", displayName: "HRB Open Research", hostName: "hrbopenresearch.org", id: "5", editorialEmail: "[email protected]", infoEmail: "[email protected]" }); Sign In Remember me Forgotten your password? Sign In Cancel Email or password not correct. Please try again Please wait... $(function(){ // Note: All the setup needs to run against a name attribute and *not* the id due the clonish // nature of facebox... $("a[id=googleSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("GOOGLE"); $("form[id=oAuthForm]").submit(); }); $("a[id=facebookSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("FACEBOOK"); $("form[id=oAuthForm]").submit(); }); $("a[id=orcidSignInButton]").click(function(event){ event.preventDefault(); $("input[id=oAuthSystem]").val("ORCID"); $("form[id=oAuthForm]").submit(); }); }); If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password. The email address should be the one you originally registered with F1000. Email address not valid, please try again You registered with F1000 via Google, so we cannot reset your password. To sign in, please click here . If you still need help with your Google account password, please click here . You registered with F1000 via Facebook, so we cannot reset your password. To sign in, please click here . If you still need help with your Facebook account password, please click here . Code not correct, please try again Reset password Cancel Email us for further assistance. Server error, please try again. If your email address is registered with us, we will email you instructions to reset your password. If you think you should have received this email but it has not arrived, please check your spam filters and/or contact for further assistance. Please wait... Register $(document).ready(function () { signIn.createSignInAsRow($("#sign-in-form-gfb-popup")); $(".target-field").each(function () { var uris = $(this).val().split("/"); if (uris.pop() === "login") { $(this).val(uris.toString().replace(",","/")); } }); }); (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'a02dcd15ae97dfa9',t:'MTc3OTk3Njk4OQ=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-4.0